Stem cell advance: Japanese scientists develop their own non-virus method for iPS cells
http://www.jsonline.com/story/index.aspx?id=804396 ...
http://www.jsonline.com/story/index.aspx?id=804396 ...
There may not be any human embryonic stem cell-derived therapies or cures, but that's understandable, according to columnist Tom Still. In this edition of Inside Wisconsin, he notes that the average drug takes 12 to 15 years to reach the market, so the lack of...
Columnist Steven S. Clark, commenting on the controversial financial rescue plan, says we've got Congressmen and women right where we want them - running for re-election after voting to pass an unpopular bailout bill. In this edition of Biotech Takes, Clark also wonders what the...
To many, this question is a no-brainer, one answered with an emphatic yes, and columnist Michael Rosen is not about to argue. In this edition of Yer Biotech Blues, Rosen talks about the some of the changes proposed by former House Speaker Newt Gingrich to...
Madison, Wis. - Quintessence Biosciences today announced the receipt of a Phase 1 Small Business Innovation Research contract from the National Cancer Institute to support the development of next generation drugs based on the EVade Ribonuclease (RNase) technology. This new class of drugs works...
In this political season, there will be a lot of claims about the benefits of embryonic stem cell research, but a little bit of perspective is in oder as politicians try to get themselves elected. That perspective was provided during the recent World Stem Cell...
When state life science companies gather Oct. 22 for the annual Wisconsin Biotechnology & Medical Device Association Conference, much of the focus will be on how to form strategic partnerships with large pharmaceutical and medical device companies. The conference, set for Wednesday, Oct. 22, will...
Madison, Wis. - Gov. Jim Doyle today announced that SAFC, Inc., of Madison will receive $292,500 in Enterprise Development Zone tax credits for its $30 million expansion project in Verona. “Wisconsin continues to be a place that pushes the frontiers of life science and discovery through...
Carolyn “Biddy” Martin might be an alumnus of the University of Wisconsin-Madison, but that wasn't the only reason she was interested in returning to her alma mater to become chancellor. The university's role in stem cell research, highlighted at last week's World Stem Cell Summit,...
Stratatech Corp. of Madison says it has successfully completed a clinical trial of a tissue-engineered skin substitute designed to regenerate skin at the wound site. The goal of the study was to evaluate the safety and efficacy of the skin substitute, known as StrataGraft, a...